"Every sucess is the mother of countless others"

Henry Ford

In-/Out-Licensing

Octreotide acetate

The active ingredient Octreotide acetate is a synthetic Somatostatin-analogon

Use

- For treatment of acromegaly

- For symptomatic treatment of endocrine tumors of the gastrointestinal tract

- For prophylaxis for postoperative pancreatic complications following pancreatic surgery

Pharmaceutical form and presentations

Solution for injection:

- 0,05 mg/ml in 1 ml ampoule

- 0,1 mg/ml in 1 ml ampoule

- 0,5 mg/ml in 1 ml ampule

- 0,2 mg/ml in 5 ml injection vial

Please note that this is not the slow release form, known as Octreotide LAR.

Application

- Subcutaneous injection

Produced in

- European Union

Available countries

- On request

 

Regulatory status, indications and product information may vary from country to country.

Product descriptions provide basic information and are not usage instructions.

Please observe the officially approved product information.

Diese Website verwendet ausschließlich technisch notwendige Cookies. Read more …